Trademarkia Logo

Canada

C$
Trademark Search in Canada
BIOVAIL

View On IC.GC.CA

BIOVAIL
REGISTERED

on 23 Apr 2007

Last Applicant/ Owned by

BAUSCH HEALTH COMPANIES INC.

2150 St. Elzéar Blvd. WestLaval

QUEBEC

CA

H7L4A8

Serial Number

1289048 filed on 7th Feb 2006

Registration Number

TMA686430 registered on 23rd Apr 2007

Registration expiry Date

23rd Apr 2032

Correspondent Address

SMART & BIGGAR LP

SCOTIA PLAZA40 KING STREET WEST40th FLOORTORONTO

ONTARIO

CA

M5H3Y2

BIOVAIL

Trademark usage description

pharmaceutical preparations and substances for the prevention, treatment and alleviation of stress; pharmaceutical preparations and substances for the Read More

Classification Information

Class [005]
Pharmaceutical preparations and substances for the prevention, treatment and alleviation of stress; pharmaceutical preparations and substances for the prevention, treatment and alleviation of diabetes; metformin; pharmaceutical preparations and substances for the prevention, treatment and alleviation of hypertension; pharmaceutical preparations and substances for the prevention, treatment and alleviation of angina; diltiazem; pharmaceutical preparations and substances for the cessation of smoking; pharmaceutical preparations and substances for the prevention and treatment of sexually transmitted diseases; pharmaceutical preparations and substances for the prevention and treatment of herpes; pharmaceutical preparations and substances for the prevention, treatment and alleviations of central nervous system disorders, diseases, conditions and ailments, namely, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, insomnia, mood disorders, bipolar disorder, seizure disorders and smoking habits or addictions; pharmaceutical preparations and substances for the prevention, treatment and alleviation of neurological disorders, diseases, conditions and ailments, namely brain injury, spinal cord injury, seizure disorders, Alzheimer's, Huntington's disease, and cerebral palsy; pharmaceutical preparations and substances for the prevention, treatment and alleviation of psychiatric disorders, diseases, conditions and ailments, namely mood disorders, anxiety disorders, panic disorders, bipolar disorders, cognitive disorders, schizophrenia, and depression; pharmaceutical preparations and substances for the prevention, treatment and alleviation of depression; anti-depressants; bupropion; pharmaceutical preparations and substances for the prevention, treatment and alleviation of sleep disorders; pharmaceutical preparations and substances for the prevention, treatment and alleviation of anxiety; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the cardio-vascular system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of acute myocardial infarctions; pharmaceutical preparations and substances for the prevention, treatment and alleviation of symptomatic congestive heart failure; pharmaceutical preparations and substances for the prevention, treatment and alleviation of asymptomatic left ventricular dysfunction; pharmaceutical preparations and substances, namely, fibrinolytic or thrombolytic agents; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the respiratory system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the endocrine system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of immunological disorders, diseases, conditions and ailments, namely autoimmune diseases, immunological deficiency syndromes, Acquired Immune Deficiency Syndrome (AIDS), immunological dysfunctions, hypersensitivity, allergies, tumors of the immunological organs; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the musculo-skeletal system, namely, bone diseases and bone degenerative conditions; pharmaceutical preparations and substances for the prevention, treatment and alleviation of pain and inflammation, namely, pain relief medication, anti-inflammatories and tramadol; pharmaceutical preparations and substances for the prevention, treatment and alleviation of migraines; pharmaceutical preparations and substances, namely, medicated skin care preparations for use in dermatology, namely, dermatitis and skin pigmentation diseases; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations and substances for use in ophthalmology; and nutritional supplements, namely, vitamins, minerals, glucosamine and chondroitin; drug delivery platforms for controlling the solubility, compressibility and/or flowability of drugs; extended release formulations, compositions and agents for use in the manufacture of human and veterinary medicinal products for the treatment of circulatory, respiratory, endocrine, neurologic, cardiovascular, alimentary, oncologic, auto-immune or immune-related, pulmonary, musculoskeletal, lymphatic, gastrointestinal, bone sensory, viral, urinary, renal, infectious, metabolic or central nervous system diseases, illnesses, disorders or conditions; extended release formulations, compositions and agents for use in the manufacture of human and veterinary medicinal products for the treatment of infertility, diabetes, and/or insulin imbalances; oral extended release pharmaceuticals for the treatment of angina and hypertension; rapidly dissolving matrix preparations for the delivery of medicinal active ingredients for the treatment of humans and for veterinary use.

Classification kind code

11

Class [035]
Registration and sales of general product lines and advanced pharmaceutical products in the field of pharmaceuticals to the order and specification of others.

Classification kind code

11

Class [040]
Manufacture of general product lines and advanced pharmaceutical products in the field of pharmaceuticals to the order and specification of others.

Classification kind code

11

Class [042]
Research and development in the field of pharmaceuticals; Formulation development, clinical evaluation and testing of pharmaceutical compounds.

Classification kind code

11

Class [045]
Regulatory registration and joint venture/licensing of pharmaceutical compounds.

Classification kind code

11

Mark Details

Serial Number

1289048

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 42
on 20th Dec 2006		Advertised
Submitted for opposition 26
on 14th Nov 2006		Approved
Submitted for opposition 135
on 13th Oct 2006		Amendment to Application
Submitted for opposition 22
on 10th Jul 2006		Search Recorded
Submitted for opposition 20
on 10th Jul 2006		Examiner's First Report
Submitted for opposition 87
on 8th Mar 2006		Rep for Service Changed
Submitted for opposition 48
on 8th Mar 2006		Agent Changed
Submitted for opposition 1
on 8th Feb 2006		Created
Submitted for opposition 31
on 8th Feb 2006		Formalized
Submitted for opposition 30
on 7th Feb 2006		Filed